Eaton to Display Terminals and Connectors at CONEXPO-CON/AGG Trade Show
9.3.2023 14:30:00 EET | Business Wire | Press release
Intelligent power management company Eaton today announced it will be displaying its line of power connectors and terminals for electrified and internal combustion construction and off-highway vehicles at the CONEXPO-CON/AGG construction trade show March 14-18 in Las Vegas.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230309005192/en/
Royal Power Solutions large LP12, LP16 and RD14 terminals are designed for vehicles typically used in construction and off-highway fields. (Photo: Business Wire)
The connectors were designed and developed by Royal Power Solutions (RPS), which Eaton acquired in 2022. Established in 1938, RPS is a global leader in the development and production of critical high-precision power- and signal-distribution terminals and connectors.
“The construction industry, like many others, is transitioning to electrification. Eaton’s global and diverse footprint has broadened our reach and ability to grow in this market,” said Chris Mancuso, general manager, Power Connections, Eaton’s eMobility business. “As the construction industry electrifies, the need for differentiating terminals and connectors evolves in parallel. We have seen a similar transition in the automotive market.”
Eaton’s portfolio of industry-leading electrical solutions includes terminals, connectors and other electrical components designed to handle current levels up to 500 amps. Among those components are stamped battery and eyelet terminals that can withstand vibration and harsh environments, making them ideal for commercial and off-highway vehicles.
High Power Lock Box connectors provide protection, superior performance
Eaton’s high power lock box (HPLB) power connectors are ideal for current and future electrified construction and off-highway vehicle solutions and can help reduce common warranty issues. The HPLB connectors offer a space-saving profile, superior performance, cost savings and reduced manufacturing complexity. The HPLB terminals provide efficiency, reliability and have stronger current carrying capabilities compared to terminals on the market today.
The HPLB terminal system forms a connection in a unique way that provides improved contact force as the temperature increases. Unlike traditional competitors’ box-and-blade or pin-and-socket terminal connections, Eaton’s HPLB terminals use an inverted contact system approach for a stronger connection.
Terminals designed for construction, aggregate industries
Part of the HPLB product line, the low-profile 12 (LP12), low-profile 16 (LP16) and round 14 (RD14) terminals are larger and designed for vehicles typically used in construction and agricultural fields. Able to carry up to 500 amps, the HPLB terminals allow global customers to simplify the manufacturing process and open new areas of opportunity for electrified off-highway vehicles.
Busbars feature low profile, flexibility to meet design requirements
Another technology now available to Eaton’s construction and off-highway vehicle customers is RigiFlex™ busbars, which can be manufactured in copper or aluminum, depending on customer requirements. With a unique, simple, single piece flow manufacturing process, Eaton can scale volume to meet any customer specification.
The RigiFlex™ busbar is rigid in some areas, but flexible in sections that require expansion, contraction or elevated changes in the system design. This flexibility also works well across the battery pack in areas that need to comply with expansion and contraction during charging and discharging cycles due to changing cell thicknesses.
Low-profile busbars enable space-efficient design without heat sinks for weight savings. Eaton also can produce busbars with a level of flatness over length unmatched by competitors.
“When off-highway equipment is assembled, it’s largely done manually since robots have difficulty handling round wires, which are hard for them to grasp,” Mancuso said. “When employing high power lock box terminals our Rigiflex™ busbars improve the assembly process, safety and time to complete the manufacturing process and with less equipment and fewer assembly personnel.”
Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for our stakeholders and all of society.
Founded in 1911, Eaton is marking its 100th anniversary of being listed on the New York Stock Exchange. We reported revenues of $20.8 billion in 2022 and serve customers in more than 170 countries. For more information, visit www.eaton.com. Follow us on Twitter and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230309005192/en/
Contact information
Thomas Nellenbach
thomasjnellenbach@eaton.com
(216) 333-2876 (cell)
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom